Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Reneo Pharmaceuticals, Inc. (RPHM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
28 Aug 2023
Hall Ashley
Chief Development Officer, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
39,600
-28%
15,625
$6.28
$98,057.81
SELL
23 Jun 2023
Novo Holdings A/S
10% Owner
Reneo Pharmaceuticals, Inc.
(RPHM)
3,330,337
-2%
100,000
$7.10
$709,740.00
BUY
1 Sep 2022
Cruse Michael
Chief Operating Officer, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
13,697
+121%
7,500
$3.39
$25,447.50
BUY
29 Aug 2022
Cruse Michael
Chief Operating Officer, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
6,197
+685%
7,255
$3.20
$23,243.39
BUY
25 Aug 2021
Jindal Vineet R.
Chief Financial Officer, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
5,000
+100%
5,000
$7.44
$37,176.50
BUY
25 Aug 2021
FLESHER GREGORY J.
President and CEO, Director, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
8,000
+100%
8,000
$8.00
$64,000.00
BUY
25 Aug 2021
Cruse Michael
Senior VP-Corporate Operations, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
2,500
+100%
2,500
$7.45
$18,616.00
BUY
14 Jul 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
2,073,957
+5%
111,736
$8.50
$949,756.00
SELL
14 Jul 2021
Johnson Wendy S.
Chief Development Officer, Officer
Reneo Pharmaceuticals, Inc.
(RPHM)
0
-100%
111,736
$8.50
$949,756.00
BUY
23 Jun 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,962,221
+1%
20,710
$9.28
$192,244.70
BUY
21 Jun 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,941,511
+2%
47,274
$8.94
$422,413.75
BUY
8 Jun 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,894,237
+0%
16,605
$9.50
$157,709.30
BUY
3 Jun 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,877,632
+0%
12,357
$9.26
$114,365.17
BUY
28 May 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,865,275
+0%
14
$9.50
$133.00
BUY
26 May 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,865,261
+0%
7,035
$9.36
$65,864.41
BUY
13 Apr 2021
New Enterprise Associates 15, L.P.
10% Owner
Reneo Pharmaceuticals, Inc.
(RPHM)
4,785,494
+16%
666,666
$15.00
$9,999,990.00
BUY
13 Apr 2021
O'Donnell Niall
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
2,063,713
+10%
200,000
$15.00
$3,000,000.00
BUY
13 Apr 2021
Muralidhar Bali
Director
Reneo Pharmaceuticals, Inc.
(RPHM)
1,858,226
+12%
200,000
$15.00
$3,000,000.00
BUY
13 Apr 2021
Novo Holdings A/S
10% Owner
Reneo Pharmaceuticals, Inc.
(RPHM)
3,430,377
+24%
666,666
$15.00
$9,999,990.00
BUY
9 Apr 2021
RiverVest Venture Fund III, L.P.
10% Owner
Reneo Pharmaceuticals, Inc.
(RPHM)
2,409,220
+9%
200,000
$15.00
$3,000,000.00
Home